PT - JOURNAL ARTICLE AU - Jing Du AU - Yuangang Pan AU - Jiyang Jiang AU - Ben C. P. Lam AU - Anbupalam Thalamuthu AU - Rory Chen AU - Ivor W. Tsang AU - Perminder S. Sachdev AU - Wei Wen TI - White matter brain age as a biomarker of cerebrovascular burden in the ageing brain AID - 10.1101/2022.02.06.22270484 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.06.22270484 4099 - http://medrxiv.org/content/early/2022/02/07/2022.02.06.22270484.short 4100 - http://medrxiv.org/content/early/2022/02/07/2022.02.06.22270484.full AB - As the brain ages, it almost invariably accumulates vascular pathology, which differentially affects the white matter. The microstructure of the white matter may therefore reveal a brain age reflecting cerebrovascular disease burden and a relationship to vascular risk factors. In this study, a white matter specific brain age was developed from diffusion weighted imaging (DWI) using a three-dimensional convolutional neural network (3D-CNN) deep learning model in both cross-sectional data from UK biobank participants (n = 37327) and a longitudinal subset (n = 1409) with an average of 2.25 years follow up. We achieved a mean absolute error (MAE) of white matter brain age prediction of 2.84 years and a Pearson’s r of 0.902 with chronological age in the test participants. The average white matter brain age gap (WMBAG) of the baseline 1409 participants with repeated scans were 0.36 ± 0.11 years younger than that of other participants in the baseline test sample with single time-point MRI scan (n = 9759). Individual vascular risk factors and the cumulative vascular risk score were significantly correlated with greater WMBAG Obesity was observed to be correlated with WMBAG only in the male participants. Participants with one, two, and three or more vascular risk factors, compared to those without any, showed an elevated WMBAG of 0.54, 1.23, and 1.94 years, respectively. Baseline WMBAG was also associated significantly with processing speed, executive and global cognition after Bonferroni correction. The significant associations of diabetes and hypertension with poor processing speed and executive function were found to be mediated through the WMBAG. However, the vascular risk factors did not associate with the two-year change in WMBAG in the longitudinal dataset. Our analysis suggests that tissue-specific brain age can be successfully targeted for the examination of the most relevant risk factors and cognition, although longer-term longitudinal data are needed to demonstrate its dynamic characteristics. The results suggest an intriguing possibility that a white matter brain age gap can serve as a potential neuroimaging biomarker for an individual’s cerebrovascular ageing process.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Health and Medical Research Council (NHMRC) of Australia Program Grants ID350833, ID568969, ID1093083 and ID630593; Jiyang Jiang was supported by John Holden Family Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from:https://www.ukbiobank.ac.uk/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe UK Biobank data used in this study can be accessed by online application (https://www.ukbiobank.ac.uk/). Codes for the 3D-CNN deep learning model in this study can be shared from the authors upon request.